NASDAQ: DERM
Journey Medical Corporation
Healthcare · Drug Manufacturers - Specialty & Generic
After hours: $6.43(0%) · as of 7:34 PM ET
Market Cap
$176.96M
52w High
$9.56
52w Low
$4.31
P/E
-17.11
Volume
389.81K
Outstanding Shares
27.52M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock fell 11.92% over the last year. Revenue grew 15% over the trailing twelve months. Operating margin moved from -12.29% to -9.8%. Free cash flow grew 3.46% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -9.8%. A decisive move in revenue — currently up 15% — would be the clearest signal to resolve the ambiguity.
Company profile
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
3
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 12, 2026
Q3 FY26 · EPS est -$0.01 · Revenue est $18.36M
View